Zydus Lifesciences Ltd Q1 FY2022-23 consolidated PAT up QoQ at Rs. 518.3 crores

Cadila Healthcare Limited has reported Consolidated financial results for the period ended June 30, 2022.

Financial Results (Q1 FY2023) - QoQ Comparison

The company has reported total income of Rs. 4138.6 crores during the period ended June 30, 2022 as compared to Rs. 3942.9 crores during the period ended March 31, 2022.

The company has posted net profit / (loss) of Rs. 518.3 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs. 397.4 crores for the period ended March 31, 2022.

The company has reported EPS of Rs. 5.06 for the period ended June 30, 2022 as compared to Rs. 3.88 for the period ended March 31, 2022.

Financials	Q1 FY2023	Q4 FY2022	% Change
Total Income	₹ 4138.6 crs	₹3942.9 crs	4.96%
Net Profit	₹518.3 crs	₹397.4 crs	30.42%
EPS	₹5.06	₹3.88	30.41%

Financial Results (Q1 FY2023) - YoY Comparison

The company has reported total income of Rs. 4138.6 crores during the period ended June 30, 2022 as compared to Rs.4033.4 crores during the period ended June 30, 2021.

The company has posted net profit / (loss) of Rs.518.3 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs.587.2 crores for the period ended June 30, 2021.

The company has reported EPS of Rs.5.06 for the period ended June 30, 2022 as compared to Rs.5.74 for the period ended June 30, 2021.

Financials	Q1 FY2023	Q1 FY2022	% Change
Total Income	₹ 4138.6 crs	₹4033.4 crs	2.61%
Net Profit	₹518.3 crs	₹587.2 crs	-11.73%
EPS	₹5.06	₹5.74	-11.85%

Shares of Cadila Healthcare Limited was last trading in BSE at Rs. 364.65 as compared to the previous close of Rs. 360.60. The total number of shares traded during the day was 55202 in over 1412 trades.

The stock hit an intraday high of Rs. 367.00 and intraday low of 358.05. The net turnover during the day was Rs. 20061686.00.

Source : Equity Bulls

Keywords

ZydusLifesciences Q1FY23 ResultUpdate